Stories > Evaxion Biotech Closes Public Offering

Evaxion Biotech Closes Public Offering

4P-Pharma Secures €15 Million Funding

AI-Powered Antigen Research Partnership

Advancements in Antibodies to Protect Im...

BioNTech's mRNA Cancer Vaccine Progress

Breakthrough Cancer Immunotherapy for Do...

Breakthrough Cancer Vaccine Shows Promis...